Publication | Closed Access

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content

Regenerative MedicineCell TherapyMarrow TransplantationHealth SciencesMedicineStem Cell TransplantationImmunologyHematologyStem Cell ResearchAutoimmunityBiomedical EngineeringStem CellsCell TransplantationMyeloablative Therapy